About Daniel Wiegand
Form D filings for EnPlusOne Biosciences from 2022 to 2024 list Daniel Wiegand as executive officer and director.
Daniel Wiegand first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Wiegand in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Wiegand works with at each company, as listed on that company's latest Form D.
EnPlusOne Biosciences Inc. · Form D/A, Dec 26, 2024
DA
Daniel Ahlstedt
Chief OperatingOfficer and director
AL
Andrew Lee
Director
SK
Steven Kasok
Director
DJ
Daniel Janse
Director